An observational study in Fear of Childbirth, LABOR PAİN and Ceserean Section, sponsored by Ankara City Hospital Bilkent. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Ankara City Hospital Bilkent · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 120 studies in Labor Pain with a site in Turkey — 23 open to participants now, 31 under way, none of them phase 3. Labor Pain · Turkey.
Among the 120 studies in Labor Pain with a site in Turkey, this one is one of 16 that started in 2026, is one of 8 observational ones, reaches primary completion later than 25 of the 30 other live ones, and was the 120th registered.
426 studies on the registry are indexed under Labor Pain; 76 are open to participants now.
Browse Labor Pain studies →23 of the 120 studies in Labor Pain with a site in Turkey are open now. Recruiting first, the newest first:
Bilecik Seyh Edebali Universitesi · Sites in Turkey
Ages 18–50 · Women only · Healthy volunteers
NURTEN ÖZÇALKAP · Sites in Turkey
Ages 18+ · Women only · Healthy volunteers
Istanbul Saglik Bilimleri University · Sites in Turkey
Ages 18–49 · Women only · Healthy volunteers
KTO Karatay University · Sites in Turkey
Ages 18–40 · Women only · Healthy volunteers
Ege University · Sites in Turkey
Ages 18–35 · Women only · Healthy volunteers
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 31 Labor Pain studies recruiting now, 8 (26%) set no upper age limit and 23 (74%) stop at 75 or younger; 3 take children under 18; 20 take healthy volunteers.
This study: 18 Years to 45 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
120 studies; the count open now beside each. This study's row is marked.
First in 2012; this study’s year is marked. 16 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 300 is above the median of 140 across 63 observational studies indexed under Labor Pain.
Median enrollment 94 across the 112 interventional studies, 150 across the 8 observational. Of the 87 that completed or were terminated, 1 (1%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 120 has an industry lead sponsor. The 10 most frequent:
Ankara City Hospital Bilkent is the lead sponsor of 450 studies on the registry; 110 are open to participants now.
Ankara City Hospital Bilkent has 5 studies filed under Labor Pain — fewer than ten, so there is no comparison to draw.
5 of the studies in Labor Pain with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07808840Sakarya UniversityUsing Wet Towel During Labor | 2026-11-30 |
| NCT07378449Istanbul University - CerrahpasaThe Effect of Hand Exercise Hoops on Labour Pain | 2026-12-15 |
| NCT07944950Ankara City Hospital BilkentFear of Childbirth and Its Association With Mode of Delivery, Labor Pain, and Epidural Analgesia Request in First-Time Mothers | 2026-12-31 |
| NCT07873814Ankara City Hospital BilkentEffect of Dural Puncture Epidural Analgesia on Oxytocin in Early vs Late Labor | 2027-05-01 |
| NCT07248787Ataturk UniversityEffect of Multi-Sensory Interventions on Labor Pain, Comfort, and Birth Satisfaction | 2027-06-30 |
Add all 5 to your calendar (.ics) → With an account.
Among the 120 studies in Labor Pain with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this observational study is to learn whether the level of fear of childbirth before active labor is related to how the baby is born, how intense labor pain is, and whether epidural pain relief is requested, in first-time mothers with a full-term pregnancy who plan a vaginal birth.
The main questions it aims to answer are:
Researchers will compare women with severe fear of childbirth (a score of 85 or higher on the Wijma Delivery Expectancy/Experience Questionnaire, version A, or W-DEQ-A) with women whose scores are below 85.
Participants will:
The study will take place at Ankara Bilkent City Hospital in Ankara, Türkiye.
BACKGROUND
Fear of childbirth (FOC) is common in pregnancy. A systematic review and meta-analysis of 29 studies including 853,988 pregnant women estimated the worldwide pooled prevalence of tocophobia at 14% (95% confidence interval 12-16%). Previous studies have linked FOC to requests for cesarean delivery without a medical indication, longer labor, greater use of epidural analgesia and a more negative birth experience. Evidence on whether fear measured before active labor predicts intrapartum outcomes in nulliparous women who plan a vaginal birth is inconsistent, and prospective data from Türkiye, which has the highest cesarean delivery rate among OECD countries, are limited.
The Wijma Delivery Expectancy/Experience Questionnaire (W-DEQ) is the most widely used instrument for measuring FOC. Version A (W-DEQ-A) assesses a woman's expectations of the coming birth during pregnancy. It consists of 33 items rated on a 6-point Likert scale (0-5), giving a total score from 0 to 165; higher scores indicate greater fear, and a score of 85 or higher is commonly used to define severe FOC. The Turkish version of the W-DEQ-A has been validated in pregnant women (Cronbach's alpha 0.89).
OBJECTIVES
Primary objective: to determine whether severe FOC (W-DEQ-A score of 85 or higher), measured before active labor, is associated with intrapartum (unplanned) cesarean delivery in nulliparous women with a term singleton pregnancy who plan a vaginal birth.
Secondary objectives: to assess the association of FOC, analyzed both as a continuous W-DEQ-A score and as a dichotomous group, with (1) mode of delivery, (2) labor pain intensity, and (3) the request for epidural labor analgesia and the cervical dilatation at which it is requested.
Exploratory objectives: to describe the duration of the active first stage and second stage of labor and the indications for intrapartum cesarean delivery according to FOC level.
DESIGN AND SETTING
This is a single-center, prospective observational cohort study conducted in the labor and delivery unit of the Department of Obstetrics and Gynecology, Ankara Bilkent City Hospital, a tertiary referral center in Ankara, Türkiye. The investigators do not assign any intervention. Labor management, induction, analgesia and decisions on operative delivery follow routine institutional practice and are made by the attending clinical team. W-DEQ-A scores will not be shared with the team managing labor, so that clinical decisions are not influenced by the study.
PARTICIPANTS AND PROCEDURES
Nulliparous women aged 18 to 45 years with a singleton, cephalic, term pregnancy (37+0 to 41+6 weeks) who are admitted for planned vaginal birth, either in the latent phase of spontaneous labor or for induction of labor, will be screened consecutively. After written informed consent, and before active labor (cervical dilatation less than 5 cm) and before any analgesia, participants will complete the Turkish W-DEQ-A in a quiet setting. Sociodemographic and obstetric characteristics will be recorded on a standardized data collection form that contains no names or national identity numbers. Labor, delivery and neonatal data will be collected prospectively by the research team and verified against medical records until discharge.
EXPOSURE
The exposure is the W-DEQ-A total score, analyzed as a continuous variable (per 10-point increase) and dichotomized at 85 (severe FOC versus non-severe FOC).
OUTCOME ASSESSMENT
COVARIATES
Prespecified potential confounders are maternal age, body mass index, education level, gestational age, attendance at antenatal education classes, onset of labor (spontaneous or induced) and birth weight. Epidural analgesia and oxytocin augmentation lie on the possible causal pathway between FOC and mode of delivery; they will be examined as mediators in sensitivity analyses rather than adjusted for in the main model.
SAMPLE SIZE
Assuming an intrapartum cesarean rate of 25% among women with a W-DEQ-A score below 85 and a 20% prevalence of severe FOC (group ratio 1:4), 460 women (92 with severe FOC and 368 without) are needed to detect an increase in the cesarean rate to 40% (relative risk 1.6; odds ratio 2.0) with 80% power and a two-sided alpha of 0.05. To allow for about 10% incomplete data or protocol deviations, 512 women will be enrolled.
STATISTICAL ANALYSIS
Continuous variables will be summarized as mean (standard deviation) or median (interquartile range) and compared with the t-test or Mann-Whitney U test; categorical variables will be compared with the chi-square or Fisher's exact test. Multivariable logistic regression will estimate the association of FOC with intrapartum cesarean delivery and with epidural request, reported as adjusted odds ratios with 95% confidence intervals. Linear regression will be used for VAS scores and for cervical dilatation at epidural request. The ability of the W-DEQ-A score to discriminate women who undergo intrapartum cesarean delivery will be explored with receiver operating characteristic (ROC) analysis. A two-sided p value below 0.05 will be considered statistically significant.
ETHICS AND DATA PROTECTION
The study will start only after approval by the Ankara Bilkent City Hospital Medical Research Scientific and Ethical Evaluation Board (TABED). Written informed consent will be obtained from all participants, who may withdraw at any time without any effect on their care. The study will be conducted in accordance with the Declaration of Helsinki (2024 revision) and Good Clinical Practice, and personal data will be processed in line with the Turkish Personal Data Protection Law (KVKK, Law No. 6698).
Nulliparous women aged 18 to 45 years with a singleton, cephalic, term pregnancy (37+0 to 41+6 weeks) who are admitted to the labor and delivery unit of Ankara Bilkent City Hospital, a tertiary referral center in Ankara, Türkiye, for planned vaginal birth, either in the latent phase of spontaneous labor or for induction of labor. Eligible women will be invited consecutively during the recruitment period.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Nulliparous women with a term singleton pregnancy planning vaginal birth whose W-DEQ-A total score at enrollment is 85 or higher, indicating severe fear of childbirth. Participants receive routine labor care; no intervention is assigned by the investigators.
Other: Wijma Delivery Expectancy/Experience Questionnaire, Version A (W-DEQ-A)
Nulliparous women with a term singleton pregnancy planning vaginal birth whose W-DEQ-A total score at enrollment is below 85. Participants receive routine labor care; no intervention is assigned by the investigators.
Other: Wijma Delivery Expectancy/Experience Questionnaire, Version A (W-DEQ-A)
Self-administered Turkish version of the W-DEQ-A: 33 items rated on a 6-point Likert scale (total score 0-165; higher scores indicate greater fear of childbirth), completed once at enrollment before active labor and before any analgesia. It is used only to measure fear of childbirth and does not change clinical care.
Rate of Intrapartum (Unplanned) Cesarean Delivery
Percentage of participants delivered by intrapartum (unplanned) cesarean section, compared between participants with a W-DEQ-A score of 85 or higher and those with a score below 85. The W-DEQ-A total score ranges from 0 to 165, with higher scores indicating greater fear of childbirth; the association with the continuous score will also be assessed.
Time frame: From enrollment to delivery during the same hospital admission (up to 7 days)
Mode of Delivery
Number and percentage of participants with spontaneous vaginal delivery, operative vaginal delivery (vacuum or forceps) and intrapartum cesarean delivery, compared between the two W-DEQ-A groups.
Time frame: At delivery (up to 7 days after enrollment)
Rate of Epidural Analgesia Request
Percentage of participants who request epidural analgesia during labor, as documented by the attending midwife or physician, regardless of whether the epidural is placed.
Time frame: From enrollment to delivery (up to 7 days)
Cervical Dilatation at the Time of Epidural Request
Cervical dilatation in centimeters (0-10 cm) at the vaginal examination performed at the time of the epidural request, among participants who request epidural analgesia. Lower values indicate an earlier request in labor.
Time frame: At the time of epidural request (during labor)
Labor Pain Intensity in Active Labor
Pain intensity measured with a 10-cm visual analogue scale (VAS; 0 = no pain, 10 = worst imaginable pain; higher scores indicate more pain) at the first vaginal examination showing cervical dilatation of 5 cm or more, before any analgesia.
Time frame: At the first vaginal examination showing cervical dilatation of 5 cm or more (active phase of labor)
Plan to share: No — Individual participant data will not be shared, in accordance with the Turkish Personal Data Protection Law (KVKK, Law No. 6698), the informed consent obtained from participants and the institutional data-use commitment of Ankara Bilkent City Hospital. Aggregated results will be published in a peer-reviewed journal.
Started Oct 2026 (actual). Primary completion is estimated for Dec 2026, 2 months after the start.
Of 31 non-industry observational studies under Labor Pain, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 32. This study's planned 2 months is below that.
Counting every sponsor, half of 32 studies reached it within 9 months; a quarter within 6 and three quarters within 32.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ankara City Hospital Bilkent →